Correlation Between Veritas Pharma and Regencell Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veritas Pharma and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veritas Pharma and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veritas Pharma and Regencell Bioscience Holdings, you can compare the effects of market volatilities on Veritas Pharma and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veritas Pharma with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veritas Pharma and Regencell Bioscience.

Diversification Opportunities for Veritas Pharma and Regencell Bioscience

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Veritas and Regencell is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Veritas Pharma and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and Veritas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veritas Pharma are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of Veritas Pharma i.e., Veritas Pharma and Regencell Bioscience go up and down completely randomly.

Pair Corralation between Veritas Pharma and Regencell Bioscience

If you would invest  482.00  in Regencell Bioscience Holdings on December 30, 2024 and sell it today you would earn a total of  2,085  from holding Regencell Bioscience Holdings or generate 432.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Veritas Pharma  vs.  Regencell Bioscience Holdings

 Performance 
       Timeline  
Veritas Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Veritas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Veritas Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Regencell Bioscience 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point.

Veritas Pharma and Regencell Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veritas Pharma and Regencell Bioscience

The main advantage of trading using opposite Veritas Pharma and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veritas Pharma position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.
The idea behind Veritas Pharma and Regencell Bioscience Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites